GPX3 and hepatocellular carcinoma: Based on the advantages that patient specific hiPSC-MSCs could be prepared as an “off-the-shelf” source with a higher capacity of self-renewal and engraftment [23], the clinical application of hiPSC-MSC-GPx3 may be a practical choice to prevent tumor recurrence and improve prognosis of HCC patients after liver surgery.